|
Abbott, Skyepharma Part Ways On Asthma Drug Flutiform
PharmaLive (press release) (subscription) It was no surprise that the two firms parted ways on the asthma drug candidate after the FDA in January said further clinical trials were needed to file for … |
View full post on asthma – Google News